top of page
News & Perspectives
Welcome to the Pyxis Partners Newsroom for the latest news releases, media and communications contact information, and policy briefs and perspectives on the most timely health topics of today authored by Pyxis Partners thought leaders.


The 118th Congress: A Dynamic and Challenging Environment
A January 2023 poll showed that only 9% of Americans believe the 118th Congress can work together in a bipartisan way. Congress has a...


Karen S. Levin named Chief Operating Officer at Pyxis Partners
Washington, DC (March 17, 2023) - Pyxis Partners, the leading public affairs and social impact firm that advances health equity, access...


Pyxis Partners congratulates Senator Tammy Baldwin
Pyxis Partners congratulates Senator Tammy Baldwin on being named Chair of Senate Appropriations Subcommittee on Labor, Health and Human...


Pyxis Partners uniquely positioned to help clinical trial sponsors meet new diversity mandate
Washington, DC (February 15, 2023) – Pyxis Partners, a Washington, DC based public affairs and social impact firm that advances health...


Chronic Houselessness in the United States
Health Outcomes, Care Delivery, and the Programs that Bridge the Gap Background In January 2022, around 127,768 individuals - nearly...


Pyxis Partners receives District of Columbia Certified Business Enterprise (CBE) Designation
Washington, DC (January 27, 2023) - Pyxis Partners, LLC, a Washington, DC-based public affairs and social impact firm that advances...


Statement on the Passage of the Respect for Marriage Act
Today the United States Congress upheld on a national level what we know to be a basic human right – to love and marry the person you...


Perspectives and Planning for the 118th Congress
The deep divide in American politics was on full display in the November elections both in numerous individual races and the resulting...


The Role of Healthcare Providers in the COVID-19 Response Moving Forward
Vaccine hesitancy has been a public health concern for years and with the emergence of the novel coronavirus, SARS-CoV-2, and quick...
bottom of page


